Perioperative chemotherapy is considered an effective treatment option for patients with gastric carcinoma. We report the results after a 7-year follow-up of a study aimed at evaluating a perioperative chemotherapy protocol in a group of patients with locally advanced gastric cancer (LAGC).
Persiani, R., Rausei, S., Pozzo, C., Biondi, A., Barone, C. A., Cananzi, F. C. M., Schinzari, G., D'Ugo, D., 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study, <<ANNALS OF SURGICAL ONCOLOGY>>, 2008; 15 (8): 2146-2152. [doi:10.1245/s10434-008-9982-2] [https://hdl.handle.net/10807/31118]
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study
Persiani, Roberto;Rausei, Stefano;Pozzo, Carmelo;Biondi, Alberto;Barone, Carlo Antonio;Cananzi, Ferdinando Carlo Maria;Schinzari, Giovanni;D'Ugo, Domenico
2008
Abstract
Perioperative chemotherapy is considered an effective treatment option for patients with gastric carcinoma. We report the results after a 7-year follow-up of a study aimed at evaluating a perioperative chemotherapy protocol in a group of patients with locally advanced gastric cancer (LAGC).
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
